Last viewed:
SNY
Prices are updated after-hours
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
(0.0% 1d)
(-2.5% 1m)
(-18.1% 1y)
(0.0% 2d)
(1.7% 3d)
(3.4% 7d)
(NaN%
volume)
Earnings Calendar:
Market Cap: $ 118,297,052,743
http://www.sanofi.com
Sec
Filling
|
Patents
| 100409 employees
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
vaccine
cardiovascular
diabetes
diabetic
add to watch list
Paper trade
email alert is off
Press-releases
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Published: 2024-04-24
(Crawled : 14:00)
- globenewswire.com
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
| 0.0%
| O: 0.82%
H: 0.0%
C: 0.0%
REGN
|
News
|
$908.32
0.11%
250K
|
Health Technology
| 0.0%
| O: -0.11%
H: 0.0%
C: 0.0%
asco
tumors
treatment
blood
for
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24
(Crawled : 05:00)
- biospace.com/
RLYB
|
News
|
$1.61
-7.47%
210K
|
| 0.0%
| O: -5.26%
H: 0.0%
C: 0.0%
JNJ
|
News
|
$148.66
-0.6%
5.2M
|
Health Technology
| 0.0%
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT
|
News
|
$0.7138
-4.24%
910K
|
Health Technology
| 0.0%
| O: -4.49%
H: 0.0%
C: 0.0%
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
| 0.0%
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT
|
News
S
|
$25.42
0.04%
230K
|
Health Technology
| 0.0%
| O: -0.29%
H: 0.0%
C: 0.0%
NKTR
|
News
|
$1.385
-2.47%
700K
|
Health Technology
| 0.0%
| O: 1.81%
H: 0.0%
C: 0.0%
MOR
|
News
|
$18.03
-0.06%
110K
|
Health Technology
| 0.0%
| O: 0.06%
H: 0.0%
C: 0.0%
GLPG
|
News
|
$28.825
-2.12%
94K
|
Health Technology
| 0.0%
| O: -0.03%
H: 0.0%
C: 0.0%
AMRN
|
News
|
$0.8747
-0.97%
510K
|
Health Technology
| 0.0%
| O: 0.91%
H: 0.0%
C: 0.0%
GOOGL
|
News
S
|
$158.54
0.18%
15M
|
Technology Services
| 0.0%
| O: 0.27%
H: 0.0%
C: 0.0%
GOOG
|
News
4
|
$160.375
0.29%
13M
|
Technology Services
| 0.0%
| O: 0.38%
H: 0.0%
C: 0.0%
OCX
|
News
|
$2.3
-6.31%
36K
|
Health Technology
| 0.0%
| O: -3.25%
H: 0.0%
C: 0.0%
biopharma
Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24
(Crawled : 12:00)
- biospace.com/
RLYB
|
News
|
$1.61
-7.47%
210K
|
| 0.0%
| O: -5.26%
H: 0.0%
C: 0.0%
JNJ
|
News
|
$148.66
-0.6%
5.2M
|
Health Technology
| 0.0%
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT
|
News
|
$0.7138
-4.24%
910K
|
Health Technology
| 0.0%
| O: -4.49%
H: 0.0%
C: 0.0%
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
| 0.0%
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT
|
News
S
|
$25.42
0.04%
230K
|
Health Technology
| 0.0%
| O: -0.29%
H: 0.0%
C: 0.0%
NKTR
|
News
|
$1.385
-2.47%
700K
|
Health Technology
| 0.0%
| O: 1.81%
H: 0.0%
C: 0.0%
MOR
|
News
|
$18.03
-0.06%
110K
|
Health Technology
| 0.0%
| O: 0.06%
H: 0.0%
C: 0.0%
GLPG
|
News
|
$28.825
-2.12%
94K
|
Health Technology
| 0.0%
| O: -0.03%
H: 0.0%
C: 0.0%
AMRN
|
News
|
$0.8747
-0.97%
510K
|
Health Technology
| 0.0%
| O: 0.91%
H: 0.0%
C: 0.0%
GOOGL
|
News
S
|
$158.54
0.18%
15M
|
Technology Services
| 0.0%
| O: 0.27%
H: 0.0%
C: 0.0%
GOOG
|
News
4
|
$160.375
0.29%
13M
|
Technology Services
| 0.0%
| O: 0.38%
H: 0.0%
C: 0.0%
OCX
|
News
|
$2.3
-6.31%
36K
|
Health Technology
| 0.0%
| O: -3.25%
H: 0.0%
C: 0.0%
biopharma
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Published: 2024-04-24
(Crawled : 13:00)
- biospace.com/
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
| 0.0%
| O: 0.82%
H: 0.0%
C: 0.0%
CVAC
|
$2.41
-7.31%
810K
|
Health Technology
| 0.0%
| O: -5.77%
H: 0.0%
C: 0.0%
BNTX
|
News
|
$88.15
-0.38%
170K
|
Health Technology
| 0.0%
| O: 0.24%
H: 0.0%
C: 0.0%
business
update
for
financial
results
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player
Published: 2024-04-24
(Crawled : 13:00)
- biospace.com/
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
| 0.0%
| O: 0.82%
H: 0.0%
C: 0.0%
car-t
sanofi
Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
Published: 2024-04-24
(Crawled : 14:00)
- biospace.com/
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
| 0.0%
| O: 0.82%
H: 0.0%
C: 0.0%
LTRN
|
News
|
$5.53
-4.16%
84K
|
Health Technology
| 0.0%
| O: 2.77%
H: 0.0%
C: 0.0%
pharma
drug
key
leaders
development
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Published: 2024-04-24
(Crawled : 15:00)
- biospace.com/
JNJ
|
News
|
$148.66
-0.6%
5.2M
|
Health Technology
| 0.0%
| O: -1.02%
H: 0.0%
C: 0.0%
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
| 0.0%
| O: 0.82%
H: 0.0%
C: 0.0%
CVAC
|
$2.41
-7.31%
810K
|
Health Technology
| 0.0%
| O: -5.77%
H: 0.0%
C: 0.0%
business
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24
(Crawled : 16:00)
- biospace.com/
ABT
|
News
|
$106.74
-0.79%
3.3M
|
Health Technology
| 0.0%
| O: -1.04%
H: 0.0%
C: 0.0%
PRGO
|
$31.145
2.15%
570K
|
Health Technology
| 0.0%
| O: 0.1%
H: 0.0%
C: 0.0%
JNJ
|
News
|
$148.66
-0.6%
5.2M
|
Health Technology
| 0.0%
| O: -1.02%
H: 0.0%
C: 0.0%
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
| 0.0%
| O: 0.82%
H: 0.0%
C: 0.0%
rare
first
opioid
approval
for
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published: 2024-04-23
(Crawled : 05:00)
- globenewswire.com
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
| 1.7%
| O: 1.7%
H: 0.0%
C: 0.0%
study
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
Published: 2024-04-23
(Crawled : 13:30)
- biospace.com/
SNY
|
News
|
$46.765
-1.94%
1.2M
|
Health Technology
| 1.7%
| O: 1.7%
H: 0.0%
C: 0.0%
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount